HCPCS Code J0744: Ciprofloxacin IV billing guide

Key Takeaways

HCPCS Code J0744 describes injection, ciprofloxacin for intravenous infusion, 200 mg, maintained by CMS under the Drugs Administered by Injection category (J0013-J7175).

CMS designates J0744 as a single-dose container code, meaning JW or JZ modifier reporting is required on every claim where the drug was dispensed from a single-dose vial.

NDC code reporting is mandatory for outpatient hospital claims billed under J0744, effective January 1, 2014, with no end date on the CMS requirement.

Practice management software like Pabau helps infusion centers and outpatient practices automate J-code claim submission, track modifier requirements, and reduce J0744 denials.

HCPCS Code J0744 covers injection, ciprofloxacin for intravenous infusion, 200 mg. It carries two billing requirements that catch practices off guard: mandatory JW/JZ modifier reporting and NDC code submission for hospital outpatient claims.

Ciprofloxacin IV belongs to the fluoroquinolone antibiotic class and is used when IV delivery is medically necessary over oral alternatives. That distinction affects how payers review these claims, which is why documentation matters as much as the code itself.

The billable unit for J0744 is 200 mg, so the units on the claim reflect the total dose given, not the number of vials opened.

A 400 mg ciprofloxacin IV infusion is billed as two units of J0744, and a 600 mg dose as three. Divide the administered dose by 200 mg and round any partial unit up to get the unit count payers expect to see.

CMS also lists J0744 as an anti-infective under the ESRD PPS Outlier Services category, meaning dialysis centers and hospital outpatient departments may encounter this code alongside other injectable antibiotics.

Pabau’s claims management software can help these practices track J0744 alongside other anti-infective codes used in outlier billing. Practices using IV therapy EMR software can also configure J0744 as a predefined service code, attaching the required modifiers and NDC data automatically at the point of order entry.

JW and JZ modifier requirements for HCPCS Code J0744

CMS has designated J0744 (CIPRO IV) as a single-dose container code in its official HCPCS Level II code set. That designation activates the JW/JZ modifier policy for every claim submitted under this code.

Here is what each modifier means in practice:

• JW modifier: Drug amount discarded or not administered to any patient from a single-dose container. Bill the administered units under J0744 and the discarded/wasted units separately, also under J0744, appended with JW.
• JZ modifier: Zero drug wastage from a single-dose container. Applies when the full vial contents were administered to the patient with no discard. JZ signals to CMS that there was no waste, removing the need to bill a separate wastage line.

When each modifier applies

Providers must document the amount drawn from the vial, the amount administered, and the amount discarded. If a 400 mg vial is opened and 200 mg is administered, the remaining 200 mg is discarded waste. Bill one unit of J0744 for the administered dose and one unit of J0744-JW for the discarded dose.

If the full vial is administered with zero discard, append JZ to the J0744 claim line. CMS audits single-dose container claims closely. Missing both JW and JZ is a compliance flag, not a minor omission. Practices seeing repeated denials on J0744 lines should verify modifier documentation is part of their standard infusion billing workflow.

Following IV therapy best practices means building modifier assignment into your charting workflow before the claim is generated, not as a billing afterthought.

NDC code reporting for J0744 claims

The National Drug Code (NDC) requirement for J0744 has been in effect since January 1, 2014, per the CMS NDC-HCPCS crosswalk list, with no scheduled end date. Outpatient hospital claims billed under J0744 must include the 11-digit NDC on the claim form.

How to report the NDC correctly

• Format: Use the 11-digit NDC in 5-4-2 format (labeler-product-package) without hyphens on electronic claims (837P/837I).
• Quantity: Report the actual quantity of drug administered in the appropriate unit of measure (UOM), not the number of vials opened.
• Unit of measure: Use the UOM code that matches the drug’s billing unit (typically ML for liquid preparations).
• NDC source: Pull the NDC from the drug package label used for that specific patient encounter, not from a general formulary list.

Physician offices billing J0744 are not always subject to the same NDC requirement as hospital outpatient departments, but many commercial payers have adopted similar policies. Verify requirements with each payer individually. Using prescription management software that logs NDC data at dispensing captures this information automatically for billing use.

Automate J-code billing with Pabau

Pabau's claims management tools let infusion clinics configure J-codes with preset modifiers and NDC fields, so your team submits complete, compliant J0744 claims the first time.

Book a demo

Medicare fee schedule and reimbursement for J0744

Medicare Part B reimburses most separately payable HCPCS J-codes under the Average Sales Price (ASP) methodology. For J0744, CMS calculates reimbursement as ASP plus 6%, updated quarterly. Because ASP-based rates change every quarter, any specific dollar amount cited without a current effective date may already be outdated.

To find the current Medicare reimbursement rate for J0744, use the CMS fee schedule tool, which reflects the most current quarterly ASP update.

The Washington State Department of Corrections fee schedule (effective January 2022) showed J0744 reimbursed at $0.95 per 200 mg unit as of that schedule, and Oregon Workers’ Compensation listed J0744 as “packaged” under their April 2025 schedule. State fee schedule rates vary significantly from Medicare ASP pricing.

Place of service considerations

Where the infusion takes place affects reimbursement. The three most common settings for J0744 billing are:

• Hospital outpatient department (POS 22): J0744 is typically packaged into the APC payment for the encounter. NDC reporting is required. The drug may not generate a separate payment line.
• Physician office (POS 11): J0744 may be separately payable under the buy-and-bill model. The physician purchases ciprofloxacin IV and bills Medicare at ASP+6%. JW/JZ modifier rules apply.
• Home infusion (POS 12): Coverage and reimbursement depend on the home infusion benefit and the specific payer. Home infusion companies typically bill the per diem service separately under S9500, alongside the drug code. Medicare coverage for home infusion of antibiotics requires meeting specific homebound and medical necessity criteria.

Ambulatory infusion centers (POS 19 or 22) billing J0744 should verify whether their MAC (Medicare Administrative Contractor) treats the drug as separately payable or packaged for their specific provider type. Practices opening an IV therapy clinic should build place-of-service billing rules into their setup before seeing their first infusion patient.

CPT administration codes billed alongside HCPCS Code J0744

The drug code J0744 covers only the ciprofloxacin itself. The infusion administration service requires a separate CPT code from the 96365-96368 range, billed on the same claim. These codes are evaluated for bundling under NCCI edits maintained by CMS.

96365 is the primary administration code when ciprofloxacin IV is the sole infused drug. Select 96367 when it follows an existing infusion already counted under 96365 for a different substance.

Most standard ciprofloxacin IV infusions run 60 minutes, making 96365 the most commonly paired code. Practices billing IV therapy documentation for antibiotic infusions should record start and stop times in the clinical note, as administration code selection depends on actual infusion duration.

When ciprofloxacin IV runs alongside other services in the same visit, only one line can be the initial service. Infusions outrank IV pushes and hydration in the CMS coding hierarchy, so a therapeutic ciprofloxacin infusion becomes the initial service even when a hydration line or IV push started earlier in the encounter.

Clear start and stop times settle which code leads and which are billed as sequential, protecting the claim if a payer reviews the sequence.

Documentation requirements for J0744 medical necessity

Ciprofloxacin IV is medically necessary only when oral administration is not feasible or clinically appropriate. CMS and most commercial payers expect the medical record to justify IV delivery over oral alternatives.

The documentation burden is higher for this code than for many other antibiotic J-codes because oral ciprofloxacin still reaches roughly 70–80% bioavailability (per FDA labeling), high enough that payers expect a specific reason IV was chosen over the tablet.

Ciprofloxacin oral vs IV bioavailability and medical necessity

Oral ciprofloxacin reaches only about 70–80% of the blood levels achieved by the IV form (per FDA labeling), but absorption is still high enough that payers ask why IV was chosen over the tablet.

Document a specific reason the oral route was ruled out, such as the patient being unable to take anything orally, a gut that cannot absorb the drug, or a severe infection needing immediate systemic levels.

Once the patient can tolerate oral intake, a ciprofloxacin IV to PO conversion is expected. Noting that switch in the chart shows the IV course was limited to the period it was truly needed, which is exactly what a payer looks for when reviewing an antibiotic infusion claim.

What the clinical note should include

• Diagnosis: The ICD-10-CM code supporting the infection requiring treatment, such as N39.0 or J13.
• Medical necessity rationale: A brief statement explaining why IV was chosen over oral administration (for example, patient unable to tolerate oral medications, severity requiring immediate systemic levels, documented failure of oral therapy).
• Drug and dose: Ciprofloxacin IV, 200 mg (or the dose administered), infusion rate, and duration.
• NDC from the specific vial: The 11-digit NDC from the package administered to this patient on this date.
• Vial data for JW/JZ: Vial size, amount drawn, amount administered, amount discarded.
• Infusion start and stop times: Required for accurate CPT administration code selection.

Practices managing IV therapy administration workflows benefit from structured documentation templates, such as this cellulitis care plan template, that prompt nurses and clinicians to capture all six data points above before the encounter is closed.

This prevents last-minute billing edits and reduces the risk of retrospective medical necessity denials during payer audits. Using digital intake forms with fields for vial lot number and NDC can embed this data capture directly into the infusion workflow.

Related HCPCS codes and common billing scenarios

J0744 sits within a cluster of injectable antibiotic J-codes. Knowing the adjacent codes reduces the risk of selecting the wrong code when the administered drug changes or when treating overlapping infection types.

Infusion centers managing antibiotic infusions across multiple drug codes benefit from mobile IV therapy billing workflows that map drug name to HCPCS code automatically, reducing manual code selection errors when treatment protocols change between visits. The IV therapy practice management system should flag modifier requirements at the point of drug selection, not at claim submission.

The AAPC’s HCPCS code lookup allows code-by-code crosswalk searches that confirm related modifiers, NDC requirements, and any NCCI edit pairs currently in effect for J0744.

Simplify J0744 billing with Pabau

J0744 billing errors almost always come down to the same two issues: missing JW/JZ modifiers and absent NDC data. Both are preventable with the right workflow structure in place before the infusion chart is closed.

Pabau lets infusion practices build J-code rules directly into their service configuration, attaching modifier prompts and NDC capture fields to every ciprofloxacin IV encounter. Staff spend less time correcting claim edits and more time on patient care. To see how Pabau handles J0744 and the full range of infusion billing codes, book a demo with the team.

Continue your research

Running an IV therapy practice? IV therapy best practices covers the operational and compliance workflows that keep infusion centers running efficiently.

Need a structured intake process for infusion patients? IV therapy intake form explains what to capture before the first drop goes in.

Exploring software built for infusion clinics? IV therapy practice management outlines the features that matter most for high-volume infusion settings.

Billing a related J-code? J0475 covers another commonly infused drug with its own modifier and documentation rules.

Frequently Asked Questions